EPW
RPRX icon

Elevated Private Wealth’s Royalty Pharma RPRX Stock Holding History

Elevated Private Wealth’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.45M Buy
+25,886
New +$1.35M 1.37% 26
2025
Q4 		$1.14M Buy
+29,557
New +$1.13M 1.18% 37

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Elevated Private Wealth's RPRX Position: Q2 2026 in Review

Elevated Private Wealth opened a new position in Royalty Pharma (RPRX) in Q2 2026: 25,886 shares worth $1.45M. The stake represents 1.37% of the portfolio and ranks #26 among its holdings. This is a return to the name: Elevated Private Wealth previously reported a position in RPRX as recently as Q4 2025.

Elevated Private Wealth first reported a position in RPRX in Q4 2025 and has held it in 2 quarters since. 643 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Elevated Private Wealth held 25,886 shares of Royalty Pharma worth $1.45M as of Q2 2026.
  • Royalty Pharma was a new Elevated Private Wealth position in Q2 2026.
  • Royalty Pharma made up 1.37% of Elevated Private Wealth's portfolio in Q2 2026, its #26 holding.
  • Elevated Private Wealth first reported a position in Royalty Pharma in Q4 2025 and has held it in 2 quarters since.
  • 643 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Elevated Private Wealth's 13F filing for Q2 2026, filed 30 Jul 2026.